Samsara BioCapital as of March 31, 2024
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 39 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp (SRRK) | 18.7 | $121M | 6.8M | 17.76 | |
| Cargo Therapeutics (CRGX) | 14.2 | $92M | 4.1M | 22.32 | |
| Mineralys Therapeutics (MLYS) | 10.1 | $66M | 5.1M | 12.91 | |
| Neurogene (NGNE) | 10.0 | $65M | 1.3M | 50.90 | |
| Nkarta (NKTX) | 6.3 | $41M | 3.8M | 10.81 | |
| Arcellx Common Stock (ACLX) | 4.9 | $32M | 454k | 69.55 | |
| Lenz Therapeutics (LENZ) | 4.2 | $27M | 1.2M | 22.33 | |
| Lyra Therapeutics | 2.7 | $17M | 2.8M | 6.22 | |
| Acelyrin | 2.6 | $17M | 2.5M | 6.75 | |
| Avadel Pharmaceuticals Sponsored Adr | 2.5 | $16M | 968k | 16.89 | |
| Jasper Therapeutics Com New (JSPR) | 2.4 | $15M | 525k | 29.36 | |
| Zymeworks Del (ZYME) | 2.4 | $15M | 1.5M | 10.52 | |
| Hillevax | 2.1 | $13M | 799k | 16.63 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.9 | $12M | 850k | 14.30 | |
| Inozyme Pharma (INZY) | 1.9 | $12M | 1.6M | 7.66 | |
| Syros Pharmaceuticals Com New (SYRS) | 1.5 | $9.6M | 1.8M | 5.35 | |
| Sutro Biopharma (STRO) | 1.5 | $9.5M | 1.7M | 5.65 | |
| Rhythm Pharmaceuticals (RYTM) | 1.2 | $7.5M | 173k | 43.33 | |
| Gossamer Bio (GOSS) | 1.1 | $7.2M | 6.1M | 1.18 | |
| Janux Therapeutics (JANX) | 1.0 | $6.8M | 180k | 37.65 | |
| Io Biotech (IOBT) | 1.0 | $6.3M | 3.6M | 1.73 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.9 | $5.6M | 348k | 16.09 | |
| Tango Therapeutics (TNGX) | 0.8 | $5.0M | 630k | 7.94 | |
| Vtv Therapeutics Cl A New (VTVT) | 0.8 | $4.9M | 207k | 23.53 | |
| Immatics SHS (IMTX) | 0.6 | $4.2M | 396k | 10.51 | |
| Adverum Biotechnologies Com New (ADVM) | 0.6 | $4.1M | 292k | 14.14 | |
| Prime Medicine (PRME) | 0.6 | $3.8M | 540k | 7.00 | |
| Day One Biopharmaceuticals I (DAWN) | 0.5 | $3.2M | 196k | 16.52 | |
| Leap Therapeutics Com New (LPTX) | 0.3 | $1.8M | 669k | 2.66 | |
| Igm Biosciences (IGMS) | 0.2 | $1.5M | 155k | 9.65 | |
| Bolt Biotherapeutics | 0.2 | $1.5M | 1.0M | 1.40 | |
| Terns Pharmaceuticals (TERN) | 0.2 | $1.3M | 202k | 6.56 | |
| Aclaris Therapeutics (ACRS) | 0.1 | $863k | 696k | 1.24 | |
| Viracta Therapeutics (VIRX) | 0.1 | $704k | 690k | 1.02 | |
| Allakos | 0.0 | $217k | 172k | 1.26 | |
| Kronos Bio | 0.0 | $102k | 78k | 1.30 | |
| Allovir (ALVR) | 0.0 | $62k | 82k | 0.75 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $40k | 133k | 0.30 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $3.0k | 100k | 0.03 |
